# Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease

> **NCT01560585** · PHASE1,PHASE2 · TERMINATED · sponsor: **University Hospitals Cleveland Medical Center** · enrollment: 3 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Isotretinoin

## Key facts

- **NCT ID:** NCT01560585
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-04
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Adverse events in 2/3 participants; study was halted but not restarted after this due to insufficnet funds as well
- **Last updated:** 2022-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01560585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01560585, "Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01560585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*